Compare HUYA & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUYA | STAA |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.7M | 867.9M |
| IPO Year | 2018 | 1995 |
| Metric | HUYA | STAA |
|---|---|---|
| Price | $2.48 | $32.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $3.50 | ★ $22.81 |
| AVG Volume (30 Days) | 775.3K | ★ 874.7K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 81.37% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $14.08 | $30.82 |
| Revenue Next Year | $6.11 | $8.41 |
| P/E Ratio | ★ N/A | $328.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.21 | $15.59 |
| 52 Week High | $4.93 | $35.87 |
| Indicator | HUYA | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 26.15 | 77.35 |
| Support Level | N/A | $23.75 |
| Resistance Level | $3.29 | $35.87 |
| Average True Range (ATR) | 0.14 | 1.50 |
| MACD | -0.06 | 0.25 |
| Stochastic Oscillator | 6.90 | 66.12 |
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.